Friday, December 21, 2012 7:05:17 PM
If you have any doubts this is all you need to ask yourself. We're talking about the freaking co-founder of Amgen, a $67 Billion company. He previously said: "I believe in MANF," said Dr. Rubinfeld, "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen." And he's presenting on the potential for commercial opportunities of MANF at a conference in January. For doubters: Do you really think they're going to present bad data in front of a conference of VC and angel investors and big pharma companies that are paying $400 to attend?
Then ask yourself why another biotech firm in the same exact field with MJFF grants was compelled to challenge their patents and even stated that the patent protection is so broad that is causes "an undue burden on anyone trying to test MANF and any of its variants".
$14 Million market cap for all of this? Puhlease. This is a friggin freight train heading higher. Anyone trying to flip it for pennies will be very sorry when it runs to $0.40+ and they're left waiting for a dip. It's going to be a $100 Million+ company very soon.
My money is with the co-founder of Amgen...
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM